glp-1 agonist medications Study finds receptor agonists target fat over muscle for weight loss GLP-1 receptor agonists – How

Several uncertainties remain

Originating in the gut, these hormones are secreted in response to nutrient intake

Expanded obesity drug coverage can increase Medicaid spending and put pressure on overall state budgets, and states are now facing tighter budget conditions and longer-term fiscal uncertainty, due in part to the federal Medicaid cuts in the 2025 reconciliation law, causing state Medicaid programs to re-evaluate their obesity drug coverage

The countrys aging population, high diabetes prevalence among older adults, and strong regulatory pathways for innovative therapies [3], influences growth

However, the dedicated HF trials were not designed to address atherosclerotic CVD outcomes